Post by
TooMuchInvested on Jan 23, 2018 4:40am
Consider this valuation.
I thought I should share this here. So I was curious about each company's share price relative to net assets to gauge at what prices each company should be worth given the amount of assets they have. Book value per share (BVPS) is a simple way compared to expected discount cash flow in determining a company's value. I can't believe CMED is that undervalued! Even is we adjust the book value to market value of assets CMED's current share price is still low. HIP BVPS @ 092017 = $0.4016 CMED BVPS @ 072017 = $111.8723 ACB BVPS @ 092017 = $12.4152
Comment by
VENMan on Jan 23, 2018 6:53am
I use Share Price to Book Value or P/B as a valuation method do to little sales most pot companies have. CMED is cheap using this method of valuation compared to peers. ALL IMO! GLTA